New AI models from the likes of Google are showing that the technology can be run on fewer Nvidia chips. Will it cause ...

TEM announces the acquisition of Deep 6 AI, enhancing its AI-driven clinical trial matching capabilities to accelerate patient recruitment and revolutionize precision medicine.

Cathie Wood’s ARK line of ETFs added more 29,845 Tempus AI (TEM) stock after the company announced the acquisition of Deep 6 AI ...

China-based DeepSeek shook up the world of generative artificial intelligence (GenAI) early this year with a low-cost but ...

Manus is making a splash right now similar to when DeepSeek debuted because it seems novel, unique, and powerful.

Google DeepMind's Gemini Robotics models are designed to enable real-world machines to interact with objects, navigate ...

Chinese innovation isn’t stopping with DeepSeek. Late last week, a Wuhan-based tech company released an AI assistant named ...

Everyone in AI is talking about Manus. We put it to the test.

AI-driven healthcare solutions provider Tempus AI (TEM) has disclosed acquisition of Deep 6 AI, a precision research platform ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Remember the last time you visited a doctor? Behind the scenes, artificial intelligence might have played a crucial role in ...

We've generated now up to 6.2 million multi-timepoint ... 2024 saw the beginning of our work in Causal AI models and in ClinTech. So we used AI models on the Tempus data and Helix data to start ...